Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vale S.A. Regulatory Filings 2013

Dec 26, 2013

30050_ffr_2013-12-26_452936a8-44f2-4041-85b0-ea04b5c21560.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

Table of Contents

*United States Securities and Exchange Commission*

*Washington, D.C. 20549*

*FORM 6-K*

*Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934*

*For the month of December 2013*

*Vale S.A.*

*Avenida Graça Aranha, No. 26 20030-900 Rio de Janeiro, RJ, Brazil*

(Address of principal executive office)

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

(Check One) Form 20-F x Form 40-F o

(Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1))

(Check One) Yes o No x

(Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7))

(Check One) Yes o No x

(Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.)

(Check One) Yes o No x

(If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b). 82- .)

SEQ.=1,FOLIO='',FILE='C:\JMS\107946\13-26977-3\task6428982\26977-3-ba.htm',USER='107946',CD='Dec 26 19:09 2013'

Table of Contents

Table of Contents:

Press Release 3
Signature Page 4

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\107946\13-26977-3\task6428982\26977-3-bc.htm',USER='107946',CD='Dec 26 19:14 2013'

Table of Contents

Press Release

*Vale sells purified phosphoric acid asset*

Rio de Janeiro, December 20, 2013 - Vale S.A. (Vale) informs that it signed an agreement with Israel Chemicals Ltd (ICL) to sell its 44.25% stake in Fosbrasil, a company that produces purified phosphoric acid in Cajati, located in the state of São Paulo, for US$ 52 million.

The conclusion of this transaction is subject to customary precedent conditions and approvals, including the approval by the Conselho Administrativo de Defesa Econômica (CADE), the Brazilian antitrust authority.

The transaction is consistent with Vale’s strategy to prioritize investment in world-class core assets and at the same time is one additional step towards simplifying Vale’s portfolio.

*For further information, please contact:*

+55-21-3814-4540

Roberto Castello Branco: [email protected]

Viktor Moszkowicz: [email protected]

Carla Albano Miller: [email protected]

Andrea Gutman: [email protected]

Marcelo Bonança Correa: [email protected]

Marcelo Lobato: [email protected]

Marcio Loures Penna: [email protected]

Samantha Pons: [email protected]

This press release may include statements that present Vale’s expectations about future events or results. All statements, when based upon expectations about the future and not on historical facts, involve various risks and uncertainties. Vale cannot guarantee that such statements will prove correct. These risks and uncertainties include factors related to the following: (a) the countries where we operate, especially Brazil and Canada; (b) the global economy; (c) the capital markets; (d) the mining and metals prices and their dependence on global industrial production, which is cyclical by nature; and (e) global competition in the markets in which Vale operates. To obtain further information on factors that may lead to results different from those forecast by Vale, please consult the reports Vale files with the U.S. Securities and Exchange Commission (SEC), the Brazilian Comissão de Valores Mobiliários (CVM), the French Autorité des Marchés Financiers (AMF), and The Stock Exchange of Hong Kong Limited, and in particular the factors discussed under “Forward-Looking Statements” and “Risk Factors” in Vale’s annual report on Form 20-F.

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\107948\13-26977-3\task6428996\26977-3-be.htm',USER='107948',CD='Dec 26 19:25 2013'

Table of Contents

*Signatures*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)
By: /s/ Roberto Castello Branco
Date: December 26, 2013 Roberto Castello Branco
Director of Investor Relations

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\107903\13-26977-3\task6428988\26977-3-bg.htm',USER='107903',CD='Dec 26 19:11 2013'